MDIC Releases Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices: Register for 10/2/20 Webinar

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

September 11, 2020

The Medical Device Innovation Consortium (MDIC) has announced the release of Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices.

MDIC states the report focuses on providing evidence-based best practices for enhancing communication with patients about medical devices so that patients can make informed treatment decisions.

“Patients considering a medical device need to understand the implications of available treatment options. This report helps decision-makers better understand how to communicate in ways that will resonate with patients,” said Scott Goates, Ph.D., Senior Advisor of Health Economics and Outcomes Research at Abbott and Chair of the Science of Patient Input Communication Working Group. The working group wrote the report on behalf of MDIC’s Science of Patient Input Steering Committee.

The MDIC report identifies characteristics of providers and patients, and the way in which the scientific and medical information is disseminated, that can affect patients’ comprehension and decision-making.

“The patient perspective that is included in this report will help physicians and medical device manufacturers understand what patients really need,” says heart patient and patient advocate Heidi Dohse. “This report provides patient insights in a way that is actionable for physicians and medical device manufacturers.”

Dohse has been living with pacemakers for 37 years since she was diagnosed with irregular junctional tachycardia at age 19. Back then, no one told her that there were different types of pacemakers and her first pacemaker wasn’t responsive to her needs as an athlete. Within six months, Dohse had a second procedure to replace her first pacemaker with another pacemaker that was better suited to her needs and goals. Dohse shares her story in the report.

“Patient engagement during the treatment decision-making process is key. This requires that all medical device stakeholders understand how to appropriately communicate with patients about medical devices,” said Pamela Goldberg, MBA, President, and CEO of MDIC. “The report is a practical resource that summarizes key terms and provides evidence-based tools, and resources to help develop an effective communication strategy.”

The report is also part of a larger movement to “make sure the patient’s voice is front and center in making decisions about medical devices,” said Goates. That movement includes MDIC’s Science of Patient Input program, which focuses on integrating the patient’s perspective and preferences in the design, clinical development, and regulatory review of innovative medical technologies.

“It’s really important that MDIC is including the patient voice and listening to the patient perspective,” said Dohse.

Read Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices.

Register for the webinar on communicating benefit, risk, and uncertainty for medical devices on Friday, October 2, 2020, at 2 pm ET.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.